drugset / Trial / NCT03240783

A Comparative Effectiveness Randomised Placebo Controlled Pilot Trial of the Management of Acute Lumbar Radicular Pain

NCT03240783

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Aim: In subjects with acute sciatica (≤ 4 weeks duration), this is a pilot comparative effectiveness study to evaluate feasibility and to determine final sample size for a future adequately powered randomised controlled trial of (i) CT-guided transforaminal lumbosacral epidural steroid injection, and (ii) oral dexamethasone, in a masked (blinded), randomised, sham injection and oral placebo controlled trial. Study Design: 60 patients with acute sciatica will randomised 1:1:1:1 to receive either (i) epidural steroid injection \& oral placebo, (ii) epidural normal saline injection \& oral placebo, (iii) oral dexamethasone \& IM sham-injection, (iv) IM sham-injection \& oral placebo. Outcomes: The primary outcome is reduction of disability at 3 weeks using the Oswestry Disability Index. Secondary outcomes include reduction of disability at 6 and 48 weeks.

Timeline

Start
2017-07-08
Primary completion
2017-12
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Betamethasone Other / unclassified 5.7 mg Other
Subject Dexamethasone Small molecule 2 mg Other
Subject Dexamethasone Small molecule 4 mg Other
Background Bupivacaine Other / unclassified 0.5 % Other
Background Lidocaine Other / unclassified 1 % Other

Indications